Artículos -

Lista de

$
0
1
-
1
1
-
1
-
1
-
1
1
1
2
3
4
5
6
7
8
9
a
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
‐
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
a
-
a
-
a
b
-
b
-
b
-
b
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
+
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
c
-
c
-
c
d
-
d
-
d
-
d
-
d
-
d
-
d
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
f
-
f
-
f
f
g
-
g
-
g
-
g
-
g
-
g
-
g
-
g
-
‐
g
-
g
-
‐
g
-
g
h
‐
h
h
-
h
-
h
-
h
-
h
i
-
i
j
k
-
k
-
k
-
k
-
k
-
k
l
-
l
-
l
-
l
-
l
-
l
-
l
l
+
l
±
l
l
m
-
m
-
m
-
m
-
m
-
m
+
m
-
m
-
m
-
m
-
‐
m
n
-
n
-
n
-
n
-
n
o
p
-
p
p
-
p
-
p
q
r
-
r
-
r
s
-
s
-
s
{
s
-
s
t
-
t
‐
-
t
-
t
-
t
t
-
t
u
v
v
w
x
-
x
y
z
α
β
—
,
δ
π
-

Sjoegren syndrome

"Anti-tissue transglutaminase antibody inhibits apoptotic cell clearance by macrophages in pregnant NOD mice" (2014) Sóñora, C.;Mourglia-Ettlin, G.;Calo, G. (...)Leirós, C.P. Journal of Reproductive Immunology. 103(1):59-66

"Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis" (2014) Hauk, V.;Fraccaroli, L.;Grasso, E. (...)Pérez Leirós, C. Clinical and Experimental Immunology. 177(3):662-670

"Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome" (2011) Hauk, V.;Calafat, M.;Larocca, L. (...)Leirós, C.P. Clinical and Experimental Immunology. 166(3):309-316

"Vasoactive intestinal peptide inhibits TNF-α-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands" (2009) Calafat, M.;Larocca, L.;Roca, V. (...)Pérez Leirós, C. Arthritis Research and Therapy. 11(2)

"Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice" (2009) Roca, V.;Calafat, M.;Larocca, L. (...)Pérez Leirós, C. Reproduction. 138(4):733-742

"NOD mice exocrinopathy: Towards a neuroimmune link" (2007) Calafat, M.; Larocca, L.; Roca, V.; Pérez Leirós, C. NeuroImmunoModulation. 14(3-4):175-181

"VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages" (2007) Larocca, L.;Calafat, M.;Roca, V. (...)Leirós, C.P. International Immunopharmacology. 7(10):1343-1349

"Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice" (2006) Roca, V.;Larocca, L.;Calafat, M. (...)Leirós, C.P. Reproduction. 132(6):931-938

"Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis" (2005) Rosignoli, F.;Roca, V.;Meiss, R. (...)Leirós, C.P. Clinical and Experimental Immunology. 142(3):411-418

"Nitric oxide synthase I and VIP-activated signaling are affected in salivary glands of NOD mice" (2002) Rosignoli, F.; Pérez Leirós, C. Journal of Neuroimmunology. 130(1-2):109-116

"Alterations in nitric oxide synthase activity and expression in submandibular glands of nod mice" (2001) Rosignoli, F.; Goren, N.B.; Pérez Leirós, C. Clinical Immunology. 101(1):86-93

"Sjögren's in adult still's disease?" (1996) Sanchez Loria, D.M.;Moreno Alvarez, M.J.;Barceló, H.A. (...)Maldonado Cocco, J.A. Clinical Rheumatology. 15(2):133-136

Navegar

Colección

Lista de